Cargando…
Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers
Background: Leprosy is manifested in varied forms based on the immune status of the patient giving rise to the polar and borderline spectrum of tuberculoid (TT) and lepromatous leprosy (LL). The present study was conducted to assess the macrophage activation in the spectrum of leprosy using CD1a and...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201461/ https://www.ncbi.nlm.nih.gov/pubmed/37223172 http://dx.doi.org/10.7759/cureus.37968 |
_version_ | 1785045267302580224 |
---|---|
author | K, Kavithamani S, Sowmya K, Shanmugasamy |
author_facet | K, Kavithamani S, Sowmya K, Shanmugasamy |
author_sort | K, Kavithamani |
collection | PubMed |
description | Background: Leprosy is manifested in varied forms based on the immune status of the patient giving rise to the polar and borderline spectrum of tuberculoid (TT) and lepromatous leprosy (LL). The present study was conducted to assess the macrophage activation in the spectrum of leprosy using CD1a and Factor XIIIa immunohistochemical markers and to correlate the macrophage expression with the morphological spectrum and bacillary index. Methodology: The present study was an observational study. Results: The present study consisted of 40 biopsy-proven leprosy cases, in which a majority were males, and the most common age group was 20-40 years. The most common type encountered was borderline tuberculoid (BT) leprosy. Expression of epidermal dendritic cells and intensity of staining by CD1a was higher in TT (seven of 10 cases (70%)) when compared to LL (one of three cases (33%)). Similarly, Factor XIIIa showed higher expression of dermal dendritic cells in 90% of TT when compared to LL which was seen in 66%. Conclusion: The increased number and strong intensity of dendritic cells in the tuberculoid spectrum may indirectly indicate macrophage activation and possibly account for the low bacillary index. |
format | Online Article Text |
id | pubmed-10201461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-102014612023-05-23 Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers K, Kavithamani S, Sowmya K, Shanmugasamy Cureus Pathology Background: Leprosy is manifested in varied forms based on the immune status of the patient giving rise to the polar and borderline spectrum of tuberculoid (TT) and lepromatous leprosy (LL). The present study was conducted to assess the macrophage activation in the spectrum of leprosy using CD1a and Factor XIIIa immunohistochemical markers and to correlate the macrophage expression with the morphological spectrum and bacillary index. Methodology: The present study was an observational study. Results: The present study consisted of 40 biopsy-proven leprosy cases, in which a majority were males, and the most common age group was 20-40 years. The most common type encountered was borderline tuberculoid (BT) leprosy. Expression of epidermal dendritic cells and intensity of staining by CD1a was higher in TT (seven of 10 cases (70%)) when compared to LL (one of three cases (33%)). Similarly, Factor XIIIa showed higher expression of dermal dendritic cells in 90% of TT when compared to LL which was seen in 66%. Conclusion: The increased number and strong intensity of dendritic cells in the tuberculoid spectrum may indirectly indicate macrophage activation and possibly account for the low bacillary index. Cureus 2023-04-22 /pmc/articles/PMC10201461/ /pubmed/37223172 http://dx.doi.org/10.7759/cureus.37968 Text en Copyright © 2023, K et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Pathology K, Kavithamani S, Sowmya K, Shanmugasamy Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers |
title | Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers |
title_full | Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers |
title_fullStr | Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers |
title_full_unstemmed | Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers |
title_short | Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers |
title_sort | dendritic cell activation in leprosy using cd1a and factor xiiia markers |
topic | Pathology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201461/ https://www.ncbi.nlm.nih.gov/pubmed/37223172 http://dx.doi.org/10.7759/cureus.37968 |
work_keys_str_mv | AT kkavithamani dendriticcellactivationinleprosyusingcd1aandfactorxiiiamarkers AT ssowmya dendriticcellactivationinleprosyusingcd1aandfactorxiiiamarkers AT kshanmugasamy dendriticcellactivationinleprosyusingcd1aandfactorxiiiamarkers |